PCLOFPHARMACIELO LTD.

About PHARMACIELO LTD. (PCLOF)

PHARMACIELO LTD. (PCLOF) is a Drug Manufacturers - Specialty & Generic company headquartered in Toronto, ON, Canada whose shares trade over-the-counter on the Pink tier.

PharmaCielo Ltd. is a global company, headquartered in Canada, with a focus on ethical and sustainable processing and supplying of all natural, medicinal-grade cannabis oil extracts and related products to large channel distributors. PharmaCielo's principal (and wholly owned) subsidiary is PharmaCielo Colombia Holdings S.A.S., headquartered at its nursery and propagation centre located in Rionegro, Colombia. The boards of directors and executive teams of both PharmaCielo and PharmaCielo Colombia Holdings are comprised of a diversely talented group of international business executives and specialists with relevant and varied expertise. PharmaCielo recognized the significant role that Colombia's ideal location will play in building a sustainable business in the medical cannabis industry, and the Company, together with its directors and executives, is executing on a business plan focused on supplying the international marketplace.

Products and services

PharmaCielo Ltd. is a global company headquartered in Canada and publicly traded on the TSXV and OTC Markets. PharmaCielo received its Colombian manufacturing licence in 2016 and has rapidly become a key player in the international medicinal cannabis sector. The company is licensed to produce both CBD-dominant and THC-dominant cannabis extracts.

PCLOF key facts

Ticker symbol

PCLOF

Market tier

Pink

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Headquarters

Toronto, ON, Canada

Country of incorporation

CA

Year of incorporation

2017

Employees

260

Estimated market cap

$9.31M (as of Apr 11, 2025)

Shares outstanding

187,983,694

Reporting standard

International Reporting: TSX Venture Exchange

Audit status

Audited

Fiscal year end

12/31

Latest filing

Quarterly Report (Sep 30, 2023)

PHARMACIELO LTD. leadership

• Marc Edward Lustig — CEO
• Bill Petron — Lead Director
• Ian Atacan — CFO
• Jon Ross — Head of IR
• Andrew Charles Newbury — Other

Explore more: Drug Manufacturers - Specialty & Generic stocks · Healthcare sector · Pink stocks · OTC stocks starting with P